市场调查报告书
商品编码
1472014
脑监测市场规模 - 按产品类型、方式、程序、应用、最终用途 - 全球预测,2024 年 - 2032 年Brain Monitoring Market Size - By Product Type, Modality, Procedure, Application, End-use - Global Forecast, 2024 - 2032 |
由于癫痫、阿兹海默症和帕金森氏症等神经系统疾病的盛行率不断增加,预计 2024 年至 2032 年,大脑监测市场规模的复合年增长率将达到 6.4%。根据世界神经病学联合会的数据,全世界约有 40% 的人口患有某种神经系统疾病,预计到 2050 年将增加一倍。
最近,医疗保健专业人员和患者对神经系统疾病早期介入重要性的认识显着提高。此外,脑部监测设备(例如脑电图(EEG)、功能性磁振造影(fMRI)和脑磁图(MEG))的技术进步提高了准确性、灵敏度和可访问性,正在推动产品的采用。
容易患神经系统疾病的老年人口不断增加,以及医疗保健支出的增加,促使政府采取措施促进大脑健康。临床环境之外不断扩大的技术应用,包括运动表现监测、认知增强和脑机介面开发,正在提供新的成长机会。此外,医疗保健组织、学术机构和技术公司之间的策略合作和伙伴关係将提高市场渗透率。
脑监测产业分为产品类型、模式、程序类型、应用、最终用途和区域。
根据应用,失智症领域的市场规模预计在 2024 年至 2032 年期间将以 6.9% 的速度成长。全球范围内痴呆症盛行率不断上升,特别是在老龄化人口中,这一点受到了支持。失智症相关认知障碍的复杂性需要全面、持续的监测,以优化患者照护和管理。此外,对失智症诊断和治疗研发的日益重视正在促进大脑监测技术的创新,从而开发出更灵敏、更准确和更易于使用的监测解决方案。
根据模式,穿戴式装置领域的大脑监测市场到 2032 年将以 6.9% 的复合年增长率成长,因为它们具有便携性,允许在传统临床环境之外持续监测大脑活动。这种可访问性可以实现即时资料收集和分析,以促进神经系统疾病的早期检测。此外,穿戴式科技的进步,例如小型化、增强的感测器功能和无线连接,有助于提高设备的舒适度、准确性和可用性,推动医疗保健专业人员和消费者的采用。
由于人口老化,欧洲脑监测产业预计在 2024 年至 2032 年期间将以 6.1% 的速度成长。该地区强大的医疗基础设施、领先的研究机构和支持性政府措施正在促进临床和研究环境中的创新和产品采用。此外,对个人化医疗和精准医疗保健的日益重视正在推动针对个别患者需求的创新脑监测解决方案的开发,进一步刺激区域市场的成长。
Brain monitoring market size is anticipated to observe 6.4% CAGR from 2024 to 2032, driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. As per World Federation of Neurology, around 40% of the population worldwide suffer from some kind of neurological condition and is anticipated to double by 2050.
Lately, the awareness among healthcare professionals and patients regarding the importance of early intervention in neurological conditions is significantly rising. Moreover, technological advancements in brain monitoring devices, such as electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and magnetoencephalography (MEG) to enhance accuracy, sensitivity, and accessibility is driving the product adoption.
The growing aging population prone to neurological disorders and an increase in healthcare expenditure are leading to government initiatives to promote brain health. The expanding technological applications beyond clinical settings, including sports performance monitoring, cognitive enhancement, and brain-computer interface development, are offering new growth opportunities. Moreover, strategic collaborations and partnerships between healthcare organizations, academic institutions, and technology companies will enhance the market penetration.
The brain monitoring industry is divided into product type, modality, type of procedure, application, end use and region.
By application, the market size from the dementia segment is slated to witness 6.9% growth rate during 2024-2032. This is favored by the rising prevalence of dementia worldwide, particularly among the aging population. The complexity of dementia-related cognitive impairments is necessitating comprehensive and continuous monitoring to optimize patient care and management. Furthermore, the growing emphasis on R&D in dementia diagnosis and treatment is fostering innovations in brain monitoring technologies, leading to the development of more sensitive, accurate, and accessible monitoring solutions.
Based on modality, the brain monitoring market from the wearable segment will grow at 6.9% CAGR through 2032, owing to their portability, allowing continuous monitoring of brain activity outside traditional clinical settings. This accessibility enables real-time data collection and analysis for facilitating early detection of neurological disorders. Moreover, advancements in wearable technology, such as miniaturization, enhanced sensor capabilities, and wireless connectivity, helps improve device comfort, accuracy, and usability, driving adoption among both healthcare professionals and consumers.
Europe brain monitoring industry is expected to expand at 6.1% rate over 2024-2032, attributed to the aging population. The presence of robust healthcare infrastructure, leading research institutions, and supportive government initiatives in the region is fostering innovation and product adoption across clinical and research settings. Furthermore, the growing emphasis on personalized medicine and precision healthcare is driving the development of innovative brain monitoring solutions tailored to individual patient needs, further stimulating the regional market growth.